Novo Stock (NVO) Tumbles. Ozempic, Wegovy Maker Has New CEO, Cuts U.S. Outlook Barron’s Novo Nordisk shares plunge 17% after Wegovy-maker cuts full-year guidance CNBC Novo Promotes Insider to CEO After Weight-Loss Drug Slowdown Bloomberg Europe shares dented as Novo warning burns $92 bln in market cap Reuters Ozempic And Wegovy Maker Cuts Outlook In Surprise Move, Picks New CEO Yahoo Finance Source link
Read More »Tag Archives: Novo
Obesity drugmaker Novo Nordisk plunges as it cuts forecasts again – Reuters
Obesity drugmaker Novo Nordisk plunges as it cuts forecasts again Reuters Novo Nordisk shares plunge 17% after Wegovy-maker cuts full-year guidance CNBC Novo Lowers Forecast as Weight-Loss Drug Sales Fall Short Bloomberg.com Ozempic And Wegovy Maker Cuts Outlook In Surprise Move, Picks New CEO Yahoo Finance Novo Nordisk issues profit warning as competition — legal and otherwise — hits Wegovy, Ozempic MarketWatch Source link
Read More »Novo Nordisk issues profit warning as competition — legal and otherwise — hits Wegovy, Ozempic – MarketWatch
Novo Nordisk issues profit warning as competition — legal and otherwise — hits Wegovy, Ozempic MarketWatch Novo Nordisk shares plunge 17% after Wegovy-maker cuts full-year guidance CNBC Obesity drugmaker Novo Nordisk cuts 2025 sales growth, operating profit outlook Yahoo Finance Novo Lowers Forecast as Weight-Loss Drug Sales Fall Short Bloomberg Novo Nordisk Stock Plummets After Ozempic, Wegovy Maker Cuts U.S. Outlook Barron’s Source link
Read More »Novo Nordisk shares plunge after Wegovy-maker cuts full-year guidance
Medical bottles and a syringe are seen with the Novo Nordisk logo displayed on a screen in the background. Nurphoto | Nurphoto | Getty Images Danish pharmaceutical giant Novo Nordisk on Tuesday cut its full-year sales and profit guidance, citing weaker growth expectations for its blockbuster Wegovy obesity drug in the key U.S. market. The company also named Maziar Mike …
Read More »